Evidence map›Paper›PMID 26727976›Full record

ArticleBMC immunology2016

Dectin-2-dependent host defense in mice infected with serotype 3 Streptococcus pneumoniae.

Yukiko Akahori, Tomomitsu Miyasaka, Masahiko Toyama, Ikumi Matsumoto, Anna Miyahara, Tong Zong, Keiko Ishii, Yuki Kinjo, Yoshitsugu Miyazaki, Shinobu Saijo and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Intracranial infections ofFrontiers in immunology · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Effects of the Dectin-2/TNF-Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yukiko AkahoriDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. nieva.divierta.vida@silk.ocn.ne.jp.
Tomomitsu MiyasakaDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. miyasaka.tomomitsu@nifty.ne.jp.
Masahiko ToyamaDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. natunohizanzouf42@yahoo.co.jp.
Ikumi MatsumotoDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. ikikmsms@gmail.com.
Anna MiyaharaDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. miyanna0407@gmail.com.
Tong ZongDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. zongtong@med.tohoku.ac.jp.
Keiko IshiiDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. ishii-k@med.tohoku.ac.jp.
Yuki KinjoDepartment of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan. ykinjo@niid.go.jp.
Yoshitsugu MiyazakiDepartment of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan. ym46@niid.go.jp.
Shinobu SaijoDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba, Japan. saijo@faculty.chiba-u.jp.
Yoichiro IwakuraCenter for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan. iwakura@rs.tus.ac.jp.
Kazuyoshi KawakamiDepartment of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Miyagi, Japan. kawakami@med.tohoku.ac.jp.
Tohoku University · JPNational Institute of Infectious Diseases · JPChiba University · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStreptococcus pneumoniae, a major causative bacterial pathogen of community-acquired pneumonia, possesses a thick polysaccharide capsule. Host defense against this bacterium is mediated by activation of innate immune cells that sense bacterial components. Recently, C-type lectin receptors (CLRs) have garnered much attention in elucidating the recognition mechanism of pathogen-derived polysaccharides.

methodsIn the present study, we first compared the clinical course and neutrophil accumulation in the lungs of Dectin-2 knock-out (KO) and wild type (WT) mice. Mice were infected intratracheally with a serotype 3 strain of S. pneumoniae, and S. pneumoniae bacterial engulfment by neutrophils and inflammatory cytokine and anti-pneumococcal polysaccharide-specific IgG levels were evaluated in bronchoalveolar lavage fluid (BALF). We also examined the effect of Dectin-2 deficiency on interleukin (IL)-12 production by bone marrow-derived dendritic cells (BM-DCs) stimulated with the bacterial components.

resultsS. pneumonia-infected Dectin-2KO mice had a shorter survival time, larger bacterial burden and lower interferon gamma (IFN-γ) production in the lungs than WT mice. Although neutrophilic infiltration in the lungs was equivalent between Dectin-2KO mice and WT mice, S. pneumonia engulfment by neutrophils was attenuated in Dectin-2KO mice compared to WT mice. The anti-pneumococcal polysaccharide-specific IgG and IgG3 levels in BALF were lower in Dectin-2KO mice than in WT mice. When BM-DCs were stimulated with S. pneumoniae culture supernatant or its Concanavalin A (ConA)-bound fraction, IL-12 production was abrogated in Dectin-2KO mice compared to WT mice.

conclusionsWe demonstrated that Dectin-2 is intimately involved in the host defense against infection with a serotype 3 strain of S. pneumoniae. Dectin-2-dependent IL-12 production may contribute to IFN-γ synthesis and subsequent production of serotype-specific anti-capsular polysaccharide IgG after S. pneumoniae infection, which may promote S. pneumoniae bacterial opsonization for engulfment.

Indexed as

SerogroupAnimalsAntibody FormationAntibody SpecificityBone Marrow CellsChemokinesDendritic CellsHost-Pathogen InteractionsInflammation MediatorsInterferon-gammaInterleukin-12Lectins, C-TypeLungMice, KnockoutNeutrophil InfiltrationNeutrophilsChemokinesdectin-2, mouseInflammation MediatorsInterferon-gammaInterleukin-12Lectins, C-Type

Identifiers

PMID26727976
PMCPMC4700738
OpenAlexW2231771424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.